Advanced Prostate Cancer Consensus Conference (APCCC)

In advanced prostate cancer, rapid and successful drug development has resulted in multiple treatment options that require careful decision-making for individual patients. Clinicians face the increasingly difficult task of choosing from multiple potentially effective treatments that also are costly and potentially toxic. Further developments in novel next-generation imaging methods, biomarkers, ...
read more ↘

 

Videos
08:09

Advanced Prostate Cancer Consensus Conference (APCCC)

Criteria for Recommending Total Therapy in Metachronous Low-Volume mHSPC

FEATURING Thomas Zilli
  • 4 views
  • December 20, 2024
10:20

Advanced Prostate Cancer Consensus Conference (APCCC)

Ideal Treatment Sequence After ADT + ARPI or ADT Alone for mHSPC

FEATURING Ian Davis
  • 6 views
  • December 9, 2024
10:04

Advanced Prostate Cancer Consensus Conference (APCCC)

Considerations for De-Escalation and Treatment Breaks in mHSPC Management

FEATURING Bertrand Tombal
  • 13 views
  • December 6, 2024
10:10

Advanced Prostate Cancer Consensus Conference (APCCC)

Combination Systemic Therapy vs. ADT+RT in mHSPC

FEATURING Robert Jones
  • 2 views
  • December 6, 2024
06:54

Advanced Prostate Cancer Consensus Conference (APCCC)

Radiation to the Primary in High Volume mHSPC

FEATURING Sandy Srinivas
  • 28 views
  • December 4, 2024
10:14

Advanced Prostate Cancer Consensus Conference (APCCC)

Ideal Treatment Sequence After ADT + ARPI + Docetaxel for mHSPC

FEATURING Karim Fizazi
  • 204 views
  • November 19, 2024
12:16

Advanced Prostate Cancer Consensus Conference (APCCC)

Managing Side Effects of PARP Inhibitors in mCRPC

FEATURING Elena Castro
  • 17 views
  • November 12, 2024
08:08

Advanced Prostate Cancer Consensus Conference (APCCC)

Optimizing Escalation Strategies for mHSPC With Unfavorable PSA Declines

FEATURING Mary-Ellen Taplin
  • 23 views
  • November 11, 2024
10:21

Advanced Prostate Cancer Consensus Conference (APCCC)

Managing mHSPC With Early Progression on Combination Therapy

FEATURING Christopher Sweeney
  • 31 views
  • November 11, 2024
  • 1
10:25

Advanced Prostate Cancer Consensus Conference (APCCC)

Guidelines for Tumor Genomic Profiling in Advanced Prostate Cancer

FEATURING Niven Mehra
  • 39 views
  • November 8, 2024
07:38

Advanced Prostate Cancer Consensus Conference (APCCC)

Managing Low-Volume Disease on Conventional Imaging vs. High-Volume on Next-Generation Imaging in Prostate Cancer

FEATURING Dana Rathkopf
  • 59 views
  • November 8, 2024
10:20

Advanced Prostate Cancer Consensus Conference (APCCC)

Best Use of PARP Inhibitors in mCRPC With BRCA1/2 Alterations

FEATURING Joaquin Mateo
  • 23 views
  • November 5, 2024
11:43

Advanced Prostate Cancer Consensus Conference (APCCC)

PARP Inhibition (Dissected): Determining Who Benefits in mCRPC

FEATURING Johann de Bono
  • 55 views
  • November 5, 2024
10:18

Advanced Prostate Cancer Consensus Conference (APCCC)

Guidance on Optimal Candidates for Triplet Systemic Therapy in mHSPC: ADT + Docetaxel + ARPI

FEATURING Nicholas James
  • 80 views
  • November 5, 2024
  • 1
11:33

Advanced Prostate Cancer Consensus Conference (APCCC)

Future Changes in the Setting of mHSPC

FEATURING Gerhardt Attard
  • 42 views
  • November 4, 2024
10:29

Advanced Prostate Cancer Consensus Conference (APCCC)

Recommended Imaging Standards for mHSPC in Daily Practice

FEATURING Michael Morris
  • 94 views
  • November 4, 2024
  • 1
08:46

Advanced Prostate Cancer Consensus Conference (APCCC)

Relevant Prognostic and Predictive Factors in mHSPC

FEATURING Matthew Smith
  • 44 views
  • October 30, 2024
09:26

Advanced Prostate Cancer Consensus Conference (APCCC)

Management of Frail Patients With mHSPC

FEATURING Maria De Santis
  • 37 views
  • October 25, 2024
09:37

Advanced Prostate Cancer Consensus Conference (APCCC)

Total Therapy Considerations in Low-Volume mHSPC: Intensification vs. De-Intensification

FEATURING Oliver Sartor
  • 168 views
  • October 23, 2024
  • 4